{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:28:21Z","timestamp":1792722501266,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>TBX4<\/jats:italic>\n                    gene, located on human chromosome 17q23.2, encodes for T-Box Transcription Factor 4, a transcription factor that belongs to the T-box gene family and it is involved in the regulation of some embryonic developmental processes, with a significant impact on respiratory and skeletal illnesses. Herein, we present the case of a female neonate with persistent pulmonary hypertension (PH) who underwent extracorporeal membrane oxygenation (ECMO) on the first day of life and then resulted to have a novel variant of the\n                    <jats:italic>TBX4<\/jats:italic>\n                    gene identified by Next-Generation Sequencing. We review the available literature about the association between PH with neonatal onset or emerging during the first months of life and mutations of the TBX4 gene, and compare our case to previously reported cases. Of 24 cases described from 2010 to 2023 sixteen (66.7%) presented with PH soon after birth. Skeletal abnormalities have been described in 5 cases (20%). Eleven cases (46%) were due to\n                    <jats:italic>de novo<\/jats:italic>\n                    mutations. Three patients (12%) required ECMO. Identification of this variant in affected individuals has implications for perinatal and postnatal management and genetic counselling. We suggest including\n                    <jats:italic>TBX4<\/jats:italic>\n                    in genetic studies of neonates with pulmonary hypertension, even in the absence of skeletal abnormalities.\n                  <\/jats:p>","DOI":"10.1186\/s13052-024-01575-3","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:25:32Z","timestamp":1709655932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neonatal persistent pulmonary hypertension related to a novel TBX4 mutation: case report and review of the literature"],"prefix":"10.1186","volume":"50","author":[{"given":"Chiara","family":"Maddaloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ronci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Umberto","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Di Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Stoppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Adorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Chello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Braguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Calzolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"4","key":"1575_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0232216","volume":"15","author":"I Hernandez-Gonzalez","year":"2020","unstructured":"Hernandez-Gonzalez I, et al. Clinical heterogeneity of pulmonary arterial hypertension associated with variants in TBX4. PLoS ONE. 2020;15(4):1\u201323.","journal-title":"PLoS ONE"},{"issue":"7","key":"1575_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1164\/rccm.202206-1039TR","volume":"207","author":"JA Karolak","year":"2023","unstructured":"Karolak JA, et al. Molecular function and contribution of TBX4 in Development and Disease. Am J Respir Crit Care Med. 2023;207(7):855\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1575_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/MCP.0000000000000678","volume":"26","author":"MG Haarman","year":"2020","unstructured":"Haarman MG, Kerstjens-Frederikse WS, Berger RMF. TBX4 variants and pulmonary diseases: getting out of the \u2018Box,\u2019 Curr. Opin Pulm Med. 2020;26(3):277\u201384.","journal-title":"Opin Pulm Med"},{"key":"1575_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.genet.39.073003.105925","volume":"39","author":"LA Naiche","year":"2005","unstructured":"Naiche LA, Harrelson Z, Kelly RG, Papaioannou VE. T-box genes in vertebrate development. Annu Rev Genet. 2005;39:219\u201339.","journal-title":"Annu Rev Genet"},{"issue":"6","key":"1575_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1086\/421331","volume":"74","author":"EMHF Bongers","year":"2004","unstructured":"Bongers EMHF, et al. Mutations in the human TBX4 gene cause small patella syndrome. Am J Hum Genet. 2004;74(6):1239\u201348.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"1575_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jmedgenet-2012-101152","volume":"50","author":"WS Kerstjens-Frederikse","year":"2013","unstructured":"Kerstjens-Frederikse WS, et al. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. J Med Genet. 2013;50(8):500\u20136.","journal-title":"J Med Genet"},{"issue":"2","key":"1575_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ajmg.a.33827","volume":"155","author":"M Nimmakayalu","year":"2011","unstructured":"Nimmakayalu M, et al. Microdeletion of 17q22q23.2 encompassing TBX2 and TBX4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension. Am J Med Genet Part A. 2011;155(2):418\u201323.","journal-title":"Am J Med Genet Part A"},{"issue":"9","key":"1575_CR8","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ajmg.a.37822","volume":"170","author":"P Szafranski","year":"2016","unstructured":"Szafranski P, et al. Phenotypic expansion of TBX4 mutations to include acinar dysplasia of the lungs. Am J Med Genet Part A. 2016;170(9):2440\u20134.","journal-title":"Am J Med Genet Part A"},{"key":"1575_CR9","doi-asserted-by":"crossref","unstructured":"Suhrie K et al. Mar., Neonatal Lung Disease Associated with <\u2009em\u2009>\u2009TBX4\u2009Mutations, J. Pediatr., vol. 206, pp. 286\u2013292.e1, 2019.","DOI":"10.1016\/j.jpeds.2018.10.018"},{"issue":"5","key":"1575_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajmg.a.61096","volume":"179","author":"K German","year":"2019","unstructured":"German K, Deutsch GH, Freed AS, Dipple KM, Chabra S, Bennett JT. Identification of a deletion containing TBX4 in a neonate with acinar dysplasia by rapid exome sequencing. Am J Med Genet Part A. 2019;179(5):842\u20135.","journal-title":"Am J Med Genet Part A"},{"key":"1575_CR11","doi-asserted-by":"crossref","unstructured":"Galambos C et al. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur Respir J, vol. 54, no. 2, 2019.","DOI":"10.1183\/13993003.01965-2018"},{"issue":"4","key":"1575_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cge.13605","volume":"96","author":"JA Karolak","year":"2019","unstructured":"Karolak JA, et al. Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity. Clin Genet. 2019;96(4):366\u201370.","journal-title":"Clin Genet"},{"key":"1575_CR13","doi-asserted-by":"crossref","unstructured":"Flanagan F, Agrawal P, Vargas SO, Raby BA, Fishman MP, Mullen M. Novel intronic TBX4 mutation Associated with Lung Disease, Pulmonary arterial hypertension and Skeletal Abnormalities with variable penetrance in a single family, no. age 32, pp. A1981\u2013A1981, 2020.","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A1981"},{"issue":"1","key":"1575_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-020-0701-6","volume":"13","author":"JA Karolak","year":"2020","unstructured":"Karolak JA, Gambin T, Honey EM, Slavik T, Popek E, Stankiewicz P. A de novo 2.2\u00a0mb recurrent 17q23.1q23.2 deletion unmasks novel putative regulatory non-coding SNVs associated with lethal lung hypoplasia and pulmonary hypertension: a case report. BMC Med Genomics. 2020;13(1):1\u20138.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"1575_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/ajmg.a.62656","volume":"188","author":"E Y\u0131ld\u0131z B\u00f6l\u00fckba\u015f\u0131","year":"2022","unstructured":"Y\u0131ld\u0131z B\u00f6l\u00fckba\u015f\u0131 E, et al. Exacerbation of mild lung disorders to lethal pulmonary hypoplasia by a noncoding hypomorphic SNV in a lung-specific enhancer in trans to the frameshifting TBX4 variant. Am J Med Genet Part A. 2022;188(5):1420\u20135.","journal-title":"Am J Med Genet Part A"},{"issue":"3","key":"1575_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pul2.12108","volume":"12","author":"SM Tsoi","year":"2022","unstructured":"Tsoi SM, et al. Persistence of persistent pulmonary hypertension of the newborn: a case of de novo TBX4 variant. Pulm Circ. 2022;12(3):2\u20135.","journal-title":"Pulm Circ"},{"key":"1575_CR17","doi-asserted-by":"crossref","unstructured":"Domingo LT et al. Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide, Front. Pediatr., vol. 10, no. December, pp. 1\u20139, 2022.","DOI":"10.3389\/fped.2022.1014922"},{"issue":"1","key":"1575_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41525-023-00350-3","volume":"8","author":"FO Flanagan","year":"2023","unstructured":"Flanagan FO, et al. An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. npj Genomic Med. 2023;8(1):1\u20135.","journal-title":"npj Genomic Med"},{"key":"1575_CR19","unstructured":"Chi A. EXTRACORPOREAL LIFE SUPPORT ORGANIZATION 30th ANNUAL ELSO CONFERENCE ABSTRACTS, pp. 97\u2013103, 2019."},{"key":"1575_CR20","doi-asserted-by":"crossref","unstructured":"Liu X et al. Aug., Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates., Respir. Res., vol. 20, no. 1, p. 174, 2019.","DOI":"10.1186\/s12931-019-1148-1"},{"issue":"8","key":"1575_CR21","doi-asserted-by":"publisher","first-page":"e1002866","DOI":"10.1371\/journal.pgen.1002866","volume":"8","author":"R Arora","year":"2012","unstructured":"Arora R, Metzger RJ, Papaioannou VE. Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system. PLoS Genet. 2012;8(8):e1002866.","journal-title":"PLoS Genet"},{"key":"1575_CR22","doi-asserted-by":"crossref","unstructured":"Akiyama H, Chaboissier M-C, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6., Genes Dev., vol. 16, no. 21, pp. 2813\u20132828, Nov. 2002.","DOI":"10.1101\/gad.1017802"},{"issue":"4","key":"1575_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1183\/13993003.00211-2016","volume":"48","author":"M Levy","year":"2016","unstructured":"Levy M, et al. Genetic analyses in a cohort of children with pulmonary hypertension. Eur Respir J. 2016;48(4):1118\u201326.","journal-title":"Eur Respir J"},{"issue":"11","key":"1575_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.recesp.2016.03.031","volume":"69","author":"P Navas","year":"2016","unstructured":"Navas P, et al. Molecular analysis of BMPR2, TBX4, and KCNK3 and genotype-phenotype correlations in Spanish patients and families with Idiopathic and Hereditary Pulmonary arterial hypertension. Rev Espa\u00f1ola Cardiol. 2016;69(11):1011\u20139. (English Ed.","journal-title":"Rev Espa\u00f1ola Cardiol"},{"issue":"2","key":"1575_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2018.12.010","volume":"104","author":"JA Karolak","year":"2019","unstructured":"Karolak JA, et al. Complex compound inheritance of Lethal Lung Developmental disorders due to disruption of the TBX-FGF pathway. Am J Hum Genet. 2019;104(2):213\u201328.","journal-title":"Am J Hum Genet"},{"key":"1575_CR26","doi-asserted-by":"crossref","unstructured":"Abman SH et al. Nov., Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society., Circulation, vol. 132, no. 21, pp. 2037\u20132099, 2015.","DOI":"10.1161\/CIR.0000000000000329"},{"key":"1575_CR27","doi-asserted-by":"crossref","unstructured":"Rosenzweig EB et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J, vol. 53, no. 1, 2019.","DOI":"10.1183\/13993003.01916-2018"},{"issue":"12","key":"1575_CR28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1164\/rccm.202203-0485OC","volume":"206","author":"M Prapa","year":"2022","unstructured":"Prapa M, et al. First genotype-phenotype study in TBX4 syndrome gain-of-function mutations causative for lung disease. Am J Respir Crit Care Med. 2022;206(12):1522\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1575_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jss.2012.07.058","volume":"177","author":"DA Lazar","year":"2012","unstructured":"Lazar DA, et al. The use of ECMO for persistent pulmonary hypertension of the newborn: a decade of experience. J Surg Res. 2012;177(2):263\u20137.","journal-title":"J Surg Res"},{"key":"1575_CR30","doi-asserted-by":"crossref","unstructured":"Clark RH et al. Feb., Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group., N. Engl. J. Med., vol. 342, no. 7, pp. 469\u2013474, 2000.","DOI":"10.1056\/NEJM200002173420704"},{"key":"1575_CR31","doi-asserted-by":"crossref","unstructured":"He Z et al. Aug., Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta-analysis., Pediatr. Pulmonol., vol. 56, no. 8, pp. 2399\u20132412, 2021.","DOI":"10.1002\/ppul.25444"},{"key":"1575_CR32","doi-asserted-by":"crossref","unstructured":"Bassler D, Kreutzer K, McNamara P, Kirpalani H. Milrinone for persistent pulmonary hypertension of the newborn., Cochrane database Syst. Rev., vol. 2010, no. 11, p. CD007802, Nov. 2010.","DOI":"10.1002\/14651858.CD007802.pub2"},{"key":"1575_CR33","doi-asserted-by":"crossref","unstructured":"Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest, vol. 93, no. 5, pp. 2141\u20138, May 1994.","DOI":"10.1172\/JCI117210"},{"key":"1575_CR34","unstructured":"Li L-X, Wei B, Yang M, Li M, Jia J-J. Efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn: a Metaanalysis., Zhongguo Dang Dai Er Ke Za Zhi, vol. 24, no. 3, pp. 319\u2013325, Mar. 2022."},{"key":"1575_CR35","doi-asserted-by":"crossref","unstructured":"Janjindamai W, Thatrimontrichai A, Maneenil G, Chanvitan P, Dissaneevate S. Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn., Indian Pediatr., vol. 50, no. 10, pp. 934\u2013938, Oct. 2013.","DOI":"10.1007\/s13312-013-0263-1"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-024-01575-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01575-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:26:48Z","timestamp":1709656008000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-024-01575-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1186\/s13052-024-01575-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The parents signed a written consent form to publish these results and the picture of their child.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interest with respect to the research, authorship and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}